Skip to content
NeoVirTech
 
  • Home
  • About
  • Services
    • Virology
    • Oncolytic viruses
    • Disinfection testing
    • Drug discovery
    • Imaging
    • Bespoke service
  • Technologies
    • Anchortm solution
    • Virus collection
    • Imaging platform
  • News
  • Contact
×
  • Home
  • About
  • Services
    • Virology
    • Oncolytic viruses
    • Disinfection testing
    • Drug discovery
    • Imaging
    • Bespoke service
  • Technologies
    • Anchortm solution
    • Virus collection
    • Imaging platform
  • News
  • Contact
 
Screenshot-2020-01-22-at-14.21.24
Cancer cells
Cancer cells infected with TG6002 ANCHORTM vaccinia virus (red), fixed and processed for immunofluorescence against LaminB (green). Nuclei counterstained with DAPI. Image acquired on a Zeiss Axiovert Z1
Composite 40207
Infected Human cells
Human cells infected with hCMV ANCHORTM (green) fixed and stained with DAPI. Image acquired on a CellInsight CX7 HCS microscope.
ad5
Human cells
Human cells expressing USP7-mCherry (red) and infected with hAdv5-ANCHORTM (green) and imaged in live 24h post infection. Early (left) and late (right) replication state can be visualized. Image acquired on a Zeiss Axiovert Z1.
SCOV2-dsRNA488-NP594-G11-20x-d_H11f03_RGB38
Infected human cells
Human cells infected with SARS-CoV-2 anf fixed 24h post infection. Nucleoprotein in red, SARS-CoV-2 RNA in green. Image acquired on a CellInsight CX7 HCS microscope.
 

Follow us

Twitter Linkedin
 
NeoVirTech
  • Home
  • About
  • Services
    • Virology
    • Oncolytic viruses
    • Disinfection testing
    • Drug discovery
    • Imaging
    • Bespoke service
  • NeoVirTech
  • Technologies
    • Anchortm solution
    • Virus collection
    • Imaging platform
  • News
  • Contact
×
  • Home
  • About
  • Services
    • Virology
    • Oncolytic viruses
    • Disinfection testing
    • Drug discovery
    • Imaging
    • Bespoke service
  • Technologies
    • Anchortm solution
    • Virus collection
    • Imaging platform
  • News
  • Contact

Creation of a platform dedicated to oncolytic viruses

Creation of a platform dedicated to oncolytic viruses

We are pleased to announce the creation of a platform dedicated to oncolytic viruses, to accelerate the time-to-market for your oncolytic viruses, from design to pre-clinical development! Don’t hesitate to contact us for more information!
contact@neovirtech.com

hashtag#virus hashtag#oncology hashtag#oncolytic

oncolytic plateform
About

Beyond virology, breakthrough technology to discover tomorrow's antivirals

  • 1, Place Pierre Potier, Oncopole
    31106 Toulouse FRANCE
  • contact@neovirtech.com
Get in touch

©2021 ComScience – Credits et legal notice – Privacy policy

We use cookies to give you the best experience on our site.

You can find out more about which cookies we are using or switch them off in .

 
NeoVirTech
Summary of privacy policy

This site uses cookies. Cookie information is stored in your browser and performs functions related to website traffic measurement, font loading. The cookies used on this site are only intended for audience measurement and are completely anonymised (hash rule).

The use of the contact form and its acceptance implies that the interlocutor agrees that his message shoulb be store by NeoVirTech agents in charge of its processing. All emails sent via this form are kept for the time required to process the request and can be deleted on request by email or via the contact form.

Cookies strictement nécessaires

Cette option doit être activée à tout moment afin que nous puissions enregistrer vos préférences pour les réglages de cookie.

Si vous désactivez ce cookie, nous ne pourrons pas enregistrer vos préférences. Cela signifie que chaque fois que vous visitez ce site, vous devrez activer ou désactiver à nouveau les cookies.